Christopher Gibson, CEO: Recursion Pharmaceuticals RXRX Sell · Filed 23/07/14

Trade details

Type: Insider sale
Amount: $247,035.18
Shares · price: 17,227 sh · $14.34 a share
Held after: 915,810 sh
Stock: Recursion Pharmaceuticals RXRX
Person: Christopher GibsonCEO
Trade date: 23/07/12
Filed: 23/07/14
Days to filing: 2 days

Sold 1.8% of holdings

Share of holding sold: 1.8%

Recursion Pharmaceuticals trades, last 26 weeks

What else happened in Recursion Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/06/12~23/08/11

Christopher Gibson's recent trades

Christopher GibsonDirector
Planned saleRecursion Pharmaceuticals
Planned sale
Recursion Pharmaceuticals
RXRX
$262K
77,290 sh
$262K
Filed 08/21
Traded 08/21
Christopher GibsonDirector
Planned saleRecursion Pharmaceuticals
Planned sale
Recursion Pharmaceuticals
RXRX
$255K
75,000 sh
$255K
Filed 08/20
Traded 08/20
Christopher GibsonDirector
Planned saleRecursion Pharmaceuticals
Planned sale
Recursion Pharmaceuticals
RXRX
$327.5K
100,000 sh
$327.5K
Filed 08/19
Traded 08/19
Christopher GibsonDirector
Planned saleRecursion Pharmaceuticals
Planned sale
Recursion Pharmaceuticals
RXRX
$80.4K
26,806 sh
$80.4K
Filed 08/18
Traded 08/18
Christopher GibsonDirector
Planned saleRecursion Pharmaceuticals
Planned sale
Recursion Pharmaceuticals
RXRX
$331K
100,000 sh
$331K
Filed 08/13
Traded 08/13